3Nagase H,Kashiwagi M.Aggrecanases and cartilage matrix degradation[J].Arithritis Res Ther,2003,5(2):94-103.
4Maroudas A,Bayliss MT,Uchitel-Kaushansky N,et al.Aggrecan turnover in human articular cartilage:Use of aspartic acid racemization as a marker of molecular age[J].Arch Biochem Biophys, 1998,350:61-71.
5Uchibori M,Nishida Y,Tabata I,et al.Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in pigmented villonodular synovitis suggests their potential role for joint destruction[J].J Rheumatol,2004,31 ( 1): 110-119.
6Gendron C,Kashiwagi M,Hughes C,et al.TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors [J].FEBS Lett,2003,555 (3): 431-436.
7Tortorella MD,Arner EC,HilIs R,et al.Alpha2-maeroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes[J].J Biol Chem,2004,279(17): 17554-17561.
8Wachsmuth L,Bau B,Fan Z, et al.ADAMTS-1,a gene product of articular chondrocytes in vivo and in vitro,is down regulated by interleukin I beta[J].J Rheumatol,2004,31 (2):315-320.
9Gleghom L,Ramesar R,Beighton P,et al.A mutation in the variable repeat region of the aggrecan gene (AGCI) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis[J].Am J Hum Genet,2005,77:484-490.
10Recklies AD,White C,Melching L,et al.Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells[J].Biochem J,2001,354:17-24.
